Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene A. P. Levy MEETING CONTRIBUTION Pages: s330 - s333
Features of macrovascular complications in type 2 diabetic patients K. Strojek MEETING CONTRIBUTION Pages: s334 - s337
Pharmacological treatment of diabetic patients with respect to prevention of macrovascular disease T. Tkác MEETING CONTRIBUTION Pages: s338 - s342
Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study A. K. GittR. Schielefor the MITRA Study Group MEETING CONTRIBUTION Pages: s343 - s347
Interventions in diabetic patients after myocardial infarction Z. MilicevicI. Raz MEETING CONTRIBUTION Pages: s348 - s353
Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarction B. Możejko-PastewkaJ. TatońThe Diabetes International Research and Education Cooperative Team (DIRECT) ORIGINAL Pages: s354 - s357
Epidemiology of cardiovascular complications in type 2 diabetes mellitus J. B. Meigs MEETING CONTRIBUTION Pages: s358 - s361
Hyperglycaemia and cardiovascular risk F. PalumboC. BianchiS. Del Prato MEETING CONTRIBUTION Pages: s362 - s369
Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients G. Jermendy MEETING CONTRIBUTION Pages: s370 - s374
Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study I. A. StrokovT. R. BursaA. S. Ametov MEETING CONTRIBUTION Pages: s375 - s379
Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved? C. Yosefy MEETING CONTRIBUTION Pages: s380 - s388
Diet and coronary heart disease in diabetes S. CerneaN. HâncuI. Raz MEETING CONTRIBUTION Pages: s389 - s400
